These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27231136)

  • 41. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.
    Huerta-Alardín AL; Varon J; Marik PE
    Crit Care; 2005 Apr; 9(2):158-69. PubMed ID: 15774072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein.
    Merroun I; El Mlili N; Martinez R; Porres JM; Llopis J; Ahabrach H; Aranda P; Sanchez Gonzalez C; Errami M; Lopez-Jurado M
    J Physiol Pharmacol; 2015 Apr; 66(2):181-90. PubMed ID: 25903949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.
    Graham DJ; Staffa JA; Shatin D; Andrade SE; Schech SD; La Grenade L; Gurwitz JH; Chan KA; Goodman MJ; Platt R
    JAMA; 2004 Dec; 292(21):2585-90. PubMed ID: 15572716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anaesthesia associated rhabdomyolysis. Diagnosis, therapy and prevention of skeletal muscle breakdown].
    Schütte JK; Gerbershagen MU; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006; 41(7-8):454-61; quiz 462-3. PubMed ID: 16874567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Drug-induced rhabdomyolysis].
    Ueda S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():567-71. PubMed ID: 18072348
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of the effect of neuropeptides and cannabinoids in gastric mucosal defense initiated centrally in the rat.
    Shujaa N; Zadori ZS; Ronai AZ; Barna I; Mergl Z; Mozes MM; Gyires K
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():93-100. PubMed ID: 20388951
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Introduction to the Endogenous Cannabinoid System.
    Lu HC; Mackie K
    Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toward a Personal Drug Detection Assistant: Machine Learning for Detection of Synthetic Cannabinoid Receptor Agonists.
    Haymond S
    Clin Chem; 2022 Jul; 68(7):869-871. PubMed ID: 35616082
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
    Tomiyama K; Funada M
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exertional heat stroke, rhabdomyolysis and susceptibility to malignant hyperthermia.
    Thomas J; Crowhurst T
    Intern Med J; 2013 Sep; 43(9):1035-8. PubMed ID: 24004393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of hospitalized rhabdomyolysis with statin and fibrate use in an insured US population.
    Amend KL; Landon J; Thyagarajan V; Niemcryk S; McAfee A
    Ann Pharmacother; 2011 Oct; 45(10):1230-9. PubMed ID: 21917557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study.
    Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J
    Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of cannabinoids and their receptors on viral infections.
    Tahamtan A; Tavakoli-Yaraki M; Rygiel TP; Mokhtari-Azad T; Salimi V
    J Med Virol; 2016 Jan; 88(1):1-12. PubMed ID: 26059175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.
    Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M
    Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
    Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of G-proteins in brain by endogenous and exogenous cannabinoids.
    Childers SR
    AAPS J; 2006 Mar; 8(1):E112-7. PubMed ID: 16584117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe rhabdomyolysis associated with pemetrexed-based chemotherapy.
    Ceribelli A; Cecere FL; Milella M; Facciolo F; Gelibter A; Cognetti F
    Lancet Oncol; 2006 Apr; 7(4):353. PubMed ID: 16574552
    [No Abstract]   [Full Text] [Related]  

  • 60. Withdrawal seizures seen in the setting of synthetic cannabinoid abuse.
    Sampson CS; Bedy SM; Carlisle T
    Am J Emerg Med; 2015 Nov; 33(11):1712.e3. PubMed ID: 25825034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.